1상모집 예정

A Study to See How Safe a New Medicine (NNC6022-0004) is in Healthy People and People Living With Obesity

연구 개요

This study is being done to look at the efficacy single and multiple ascending dose study investigating safety, tolerability, pharmacokinetics, food effect and target engagement in healthy adults including a single cohort in adults living with obesity. Participants will either get NNC6022-0004, (the treatment being tested) or Placebo (a treatment that has no active medicine in it) and which treatment participants get is decided by chance.

스폰서
리드: 노보노디스크
적응증
Obesity, Elevated High-sensitivity C-reactive Protein (hsCRP)
중재
NNC6022-0004, Placebo
목표 등록
128
시작일
2026-07-06
완료(예정)
2027-08-01

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.